Cardiovascular disease (CVD) is the most common cause of death in NAFLD patients. Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH ...

As mentioned earlier, finding out whether a patient has NASH requires an in-hospital liver biopsy. An NAFLD diagnosis also offers no insights into the etiology of the patient’s disease ...

Blood-based biomarkers offer a number of advantages over the traditional standard of fibrosis assessment of liver biopsy ... alcoholic and non-alcoholic fatty liver disease.

Pune, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The SNS Insider report indicates that, “ The Liver Biopsy Market size was about USD 0 ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

NAFLD doesn’t have any physical symptoms, which makes it virtually impossible to identify without blood tests or a liver ...

Glycated haemoglobin may predict disease severity in patients with NAFLD, a study published in the Diabetes Research and ...

The most accurate way to diagnose fatty liver disease is a liver biopsy, in which a small sample of liver tissue is removed for lab testing. There is no approved drug treatment for non-alcoholic fatty ...

Advances in minimally invasive biopsy techniques and the rising incidence of liver disorders, including non-alcoholic fatty liver disease and cirrhosis, are driving market growth. In addition ...